Publications by authors named "Thomas Lycan"

Claim this Profile
T
The evolution of clinical practice guidelines for the postoperative treatment of human papillomavirus-associated oropharyngeal squamous cell carcinoma: comments and controversies.
Ryan T Hughes, William A Stokes, Niema B Razavian, David M Routman, Thomas W Lycan

Pract Radiat Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of a genomic signature for oligometastatic non-small cell lung cancer.
Ariel R Choi, Ralph B D'Agostino, Claire M Lanier, Sarah Glynn, Patrick Young, Thomas W Lycan

J Radiosurg SBRT· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of comorbidity on immune-related adverse events and survival in older cancer patients treated with immunotherapy.
Alyssa A Guo, Mary-Peyton Knapp, Joni K Evans, Andrew T Faucheux, Sarah N Price, Thomas W Lycan

Future Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IASLC grading system predicts distant metastases for resected lung adenocarcinoma.
Yuezhu Wang, Margaret R Smith, Caroline B Dixon, Ralph D'Agostino, Yin Liu, Thomas Lycan

J Clin Pathol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase 2 trial of pembrolizumab alone or in combination with low dose chemotherapy for patients with non-small cell lung cancer and poor performance status.
Safoa Addo, Thomas Lycan, David R Soto-Pantoja, Yu-Ting Tsai, Ericson Stoen

Lung Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small-Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases?
Sarah E Glynn, Claire M Lanier, Ariel R Choi, Ralph D'Agostino, Michael Farris, Thomas Lycan

Cancers (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational Profile of Blood and Tumor Tissue and Biomarkers of Response to PD-1 Inhibitors in Patients with Cutaneous Squamous Cell Carcinoma.
Mark J Chang, Daniel B Stamos, Cetin Urtis, Nathan L Bowers, Lauren M Schmalz, Thomas W Lycan

Cancers (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival impact of immune-related adverse events in extensive stage small cell lung cancer patients: a retrospective cohort study.
John C Hunting, Sarah N Price, Andrew T Faucheux, Eric Olson, Catherine A Elko, Thomas William Lycan

Immunotherapy· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations Associated With High-Grade irAEs in NSCLC Patients Receiving Immunotherapies.
Margaret R Smith, Yuezhu Wang, Caroline B Dixon, Ralph D'Agostino, Yin Liu, Thomas Lycan

Clin Lung Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non-Small Cell Lung Cancer.
Margaret R Smith, Caroline B Dixon, Yuezhu Wang, Yin Liu, Ralph D'Agostino, Thomas Lycan

Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COPD and Immune Checkpoint Inhibitors for Cancer: A Literature Review.
Thomas W Lycan, Dustin L Norton, Jill A Ohar

Int J Chron Obstruct Pulmon Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association Between an Electronic Health Record (EHR)-Embedded Frailty Index and Patient-Reported Outcomes Among Patients with Metastatic Non-Small-Cell Lung Cancer on Immunotherapy: A Brief Report.
Jennifer Gabbard, Saadia Nur, Beverly J Levine, Thomas W Lycan, Nicholas Pajewski

Am J Hosp Palliat Care· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases.
Ariel R Choi, Ralph B D'Agostino, Michael K Farris, Mohammed Abdulhaleem, John C Hunting, Thomas W Lycan

Front Endocrinol (Lausanne)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-Related Adverse Events of Genitourinary Cancer Patients, a Retrospective Cohort Study.
John C Hunting, Logan Deyo, Eric Olson, Andrew T Faucheux, Sarah N Price, Thomas W Lycan

Cancers (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of neurological adverse events among a retrospective cohort of patients receiving immune checkpoint inhibitors.
John C Hunting, Andrew T Faucheux, Sarah N Price, Catherine A Elko, Alexander Quattlebaum, Thomas W Lycan

Immunotherapy· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Keratin-based topical cream for radiation dermatitis during head and neck radiotherapy: a randomised, open-label pilot study.
Ryan T Hughes, Beverly J Levine, Bart A Frizzell, Kathryn M Greven, Mercedes Porosnicu, Thomas W Lycan

J Radiother Pract· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer.
Kimberly M Burcher, Chance H Bloomer, Elena Gavrila, John M Kalada, Mark J Chang, Thomas W Lycan

Ther Adv Med Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastases.
Mohammed Abdulhaleem, John C Hunting, Yuezhu Wang, Margaret R Smith, Ralph D' Jr Agostino, Thomas Lycan

Front Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer.
Ryan T Hughes, Rediet R Gebeyehu, John Mason Kalada, Thomas W Lycan, Bart A Frizzell

Future Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Awareness, Palliative Care Use, and Barriers to Palliative Care in Patients Undergoing Immunotherapy or Chemo-Immunotherapy for Metastatic Lung Cancer.
Laurie E McLouth, Jennifer Gabbard, Beverly J Levine, Shannon L Golden, Thomas W Lycan

J Palliat Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
c-Met Mediated Cytokine Network Promotes Brain Metastasis of Breast Cancer by Remodeling Neutrophil Activities.
Yin Liu, Margaret R Smith, Yuezhu Wang, Ralph D'Agostino, Jimmy Ruiz, Thomas Lycan

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapy.
Margaret R Smith, Yuezhu Wang, Ralph D'Agostino, Yin Liu, Jimmy Ruiz, Thomas Lycan

NPJ Precis Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Workflow to Create a Checkpoint Inhibitor Pneumonitis Patient Registry.
Andrew Faucheux, Eric Olson, Jeffrey Lantz, Nathan Roberts, Vanya Aggarwal, Thomas Lycan

Cureus· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case Report of Immune Checkpoint Inhibitor-Induced Aortitis Treated with Tocilizumab.
Chance H Bloomer, Rahul V Annabathula, Vanya Aggarwal, Bharathi Upadhya, Thomas W Lycan

Case Reports Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early [18]FDG PET/CT scan predicts tumor response in head and neck squamous cell cancer patients treated with erlotinib adjusted per smoking status.
Mercedes Porosnicu, Anderson O'Brien Cox, Joshua D Waltonen, Paul M Bunch, Ralph D'Agostino, Thomas W Lycan

Front Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis